293 related articles for article (PubMed ID: 10647762)
41. Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.
Harenberg J; Stehle G; Blauth M; Huck K; Mall K; Heene DL
Semin Thromb Hemost; 1997; 23(1):83-90. PubMed ID: 9156415
[TBL] [Abstract][Full Text] [Related]
42. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.
Büller HR; Davidson BL; Decousus H; Gallus A; Gent M; Piovella F; Prins MH; Raskob G; van den Berg-Segers AE; Cariou R; Leeuwenkamp O; Lensing AW;
N Engl J Med; 2003 Oct; 349(18):1695-702. PubMed ID: 14585937
[TBL] [Abstract][Full Text] [Related]
43. Subcutaneous unfractionated heparin compared with low-molecular-weight heparin for the initial treatment of venous thromboembolism.
Bernardi E; Prandoni P
Curr Opin Pulm Med; 2005 Sep; 11(5):363-7. PubMed ID: 16093806
[TBL] [Abstract][Full Text] [Related]
44. [Prevention of venous thromboembolism in polytraumatized patients. Epidemiology and importance].
Venet C; Berger C; Tardy B; Viallon A; Decousus H; Bertrand JC
Presse Med; 2000 Jan; 29(2):68-75. PubMed ID: 10682030
[TBL] [Abstract][Full Text] [Related]
45. Enoxaparin in the treatment of deep vein thrombosis with or without pulmonary embolism: an individual patient data meta-analysis.
Mismetti P; Quenet S; Levine M; Merli G; Decousus H; Derobert E; Laporte S
Chest; 2005 Oct; 128(4):2203-10. PubMed ID: 16236875
[TBL] [Abstract][Full Text] [Related]
46. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
[TBL] [Abstract][Full Text] [Related]
47. Heparin and low molecular weight heparin for treatment of acute pulmonary embolism.
Raskob GE
Curr Opin Pulm Med; 1999 Jul; 5(4):216-21. PubMed ID: 10407690
[TBL] [Abstract][Full Text] [Related]
48. Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis.
Belcaro G; Nicolaides AN; Cesarone MR; Laurora G; De Sanctis MT; Incandela L; Barsotti A; Corsi M; Vasdekis S; Christopoulos D; Lennox A; Malouf M
Angiology; 1999 Oct; 50(10):781-7. PubMed ID: 10535716
[TBL] [Abstract][Full Text] [Related]
49. Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrations.
Bellosta R; Ferrari P; Luzzani L; Carugati C; Cossu L; Talarico M; Sarcina A
Angiology; 2007; 58(3):316-22. PubMed ID: 17626986
[TBL] [Abstract][Full Text] [Related]
50. Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis.
Prandoni P; Lensing AW; Büller HR; Carta M; Cogo A; Vigo M; Casara D; Ruol A; ten Cate JW
Lancet; 1992 Feb; 339(8791):441-5. PubMed ID: 1346817
[TBL] [Abstract][Full Text] [Related]
51. A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture.
Monreal M; Lafoz E; Navarro A; Granero X; Caja V; Caceres E; Salvador R; Ruiz J
J Trauma; 1989 Jun; 29(6):873-5. PubMed ID: 2544742
[TBL] [Abstract][Full Text] [Related]
52. Heparin and low-molecular-weight heparin in the treatment of venous thromboembolism.
Pineo GF; Hull RD
Baillieres Clin Haematol; 1998 Sep; 11(3):621-37. PubMed ID: 10331096
[TBL] [Abstract][Full Text] [Related]
53. Multidetector-row computed tomography-based clinical assessment of fondaparinux for treatment of acute pulmonary embolism and acute deep vein thrombosis in Japanese patients.
Nakamura M; Okano Y; Minamiguchi H; Munemasa M; Sonoda M; Yamada N; Hanzawa K; Aoyagi N; Tsujimoto H; Sarai N; Nakajima H; Kunieda T
Circ J; 2011; 75(6):1424-32. PubMed ID: 21512258
[TBL] [Abstract][Full Text] [Related]
54. Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once- or twice-daily low-molecular-weight heparin.
Partsch H; Kechavarz B; Mostbeck A; Köhn H; Lipp C
J Vasc Surg; 1996 Nov; 24(5):774-82. PubMed ID: 8918323
[TBL] [Abstract][Full Text] [Related]
55. [Treatment and prophylaxis of deep venous thrombosis with low molecular weight heparins (meta-analysis of clinical trials)].
Valiukiene L; Naudziūnas A; Unikauskas A
Medicina (Kaunas); 2003; 39(4):352-8. PubMed ID: 12738903
[TBL] [Abstract][Full Text] [Related]
56. Fixed-dose, body weight-independent subcutaneous low molecular weight heparin Certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosis.
Riess H; Koppenhagen K; Tolle A; Kemkes-Matthes B; Gräve M; Patek F; Drexler M; Siemens HJ; Harenberg J; Weidinger G; Brom J; Haas S;
Thromb Haemost; 2003 Aug; 90(2):252-9. PubMed ID: 12888872
[TBL] [Abstract][Full Text] [Related]
57. Heparin therapy for venous thrombosis and pulmonary embolism.
Raskob GE; Carter CJ; Hull RD
Blood Rev; 1988 Dec; 2(4):251-8. PubMed ID: 3061531
[TBL] [Abstract][Full Text] [Related]
58. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.
Decousus H; Leizorovicz A; Parent F; Page Y; Tardy B; Girard P; Laporte S; Faivre R; Charbonnier B; Barral FG; Huet Y; Simonneau G
N Engl J Med; 1998 Feb; 338(7):409-15. PubMed ID: 9459643
[TBL] [Abstract][Full Text] [Related]
59. Treatment of established deep vein thrombosis: a review of the therapeutic armamentarium.
Berkowitz SD
Orthopedics; 1995 Jul; 18 Suppl():18-20. PubMed ID: 7479421
[TBL] [Abstract][Full Text] [Related]
60. Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis.
Chong BH; Brighton TA; Baker RI; Thurlow P; Lee CH;
J Thromb Thrombolysis; 2005 Jun; 19(3):173-81. PubMed ID: 16082604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
